BioRestorative Therapies (BRTX) EPS (Basic) (2010 - 2025)
BioRestorative Therapies' (BRTX) quarterly EPS (Basic) came in at -$2.94 in Q4 2025, down 734.11% YoY from $0.46 in Q4 2024, and down 621.77% on a QoQ basis from -$0.41 in Q3 2025.
BioRestorative Therapies (BRTX) EPS (Basic) (2010 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 16 years of EPS (Basic) data on file, last reported at -$2.94 in Q4 2025.
- Quarterly EPS (Basic) fell 734.11% year-over-year to -$2.94 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.36 (down 188.22% YoY) and the FY2025 annual result came in at -$4.25, up 19.48% from the prior year.
- EPS (Basic) fell to -$2.94 in Q4 2025, from -$0.41 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.28 in Q3 2024 to a low of -$20.68 in Q1 2021.
- A 5-year average of -$2.47 and a median of -$1.04 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) surged 93.01% — and 2025, when it slumped 734.11%.
- Tracing BRTX's EPS (Basic) over 5 years: stood at -$3.41 in 2021, then soared by 61.71% to -$1.31 in 2022, then soared by 40.75% to -$0.77 in 2023, then surged by 54.48% to -$0.35 in 2024, then sank by 734.11% to -$2.94 in 2025.
- The last three EPS (Basic) figures came in at -$2.94 (Q4 2025), -$0.41 (Q3 2025), and -$0.42 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | BioRestorative Therapies | 2.00 Mn | -953,752.60 | 17,964.00 | -0.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.94 |
| Sep 30, 2025 | -0.41 |
| Jun 30, 2025 | -0.42 |
| Mar 31, 2025 | -0.64 |
| Dec 31, 2024 | -0.35 |
| Sep 30, 2024 | -0.28 |
| Jun 30, 2024 | -0.30 |
| Mar 31, 2024 | -0.64 |
| Dec 31, 2023 | -0.77 |
| Sep 30, 2023 | -0.68 |
| Jun 30, 2023 | -0.81 |
| Mar 31, 2023 | -1.57 |
| Dec 31, 2022 | -1.31 |
| Sep 30, 2022 | -1.28 |
| Jun 30, 2022 | -1.29 |
| Mar 31, 2022 | -1.45 |
| Dec 31, 2021 | -3.41 |
| Sep 30, 2021 | -4.99 |
| Jun 30, 2021 | -5.20 |
| Mar 31, 2021 | -20.68 |